Servier China

Servier China stands as a prominent international pharmaceutical group, committed to providing innovative medical solutions. With a strong foundation built over decades, Servier China has emerged as a leader in addressing critical healthcare needs, particularly in the management of cardiovascular diseases, diabetes, and venous diseases, reaching 3 million Chinese patients daily.

Servier China's dedication extends to pioneering research and development, focusing on innovative medicines for immune-inflammatory diseases, neuropsychiatry, and oncology. Its state-of-the-art production plant in Tianjin ensures the availability of Servier’s leading brands to patients in China and other Asian countries, with a capacity expanded to 120 million standard boxes to meet growing patient needs. Servier China operates across 27 provinces and cities, driven by over 1000 employees committed to improving patient outcomes.

Servier China continues to expand its landscape, particularly in the field of oncology, addressing hard-to-treat cancers like colorectal cancer, glioma, and liquid tumors. With its robust commercial operations, R&D capabilities, and efficient production, Servier China remains dedicated to advancing healthcare and improving the quality of life for patients across the region. We invite the manager of Servier China to create a customized and exclusive company showcase and product listing on our platform.